Two delivery routes. One conservative dosing standard.

Topical cannabinoid delivery is, by design, local — the actives interact with CB receptors in the skin and underlying tissue with minimal systemic crossing. That's the entire point of the category and the reason topicals work for targeted recovery without a systemic dose to track or stack.

Topical application of a broad-spectrum (ND-THC) cream or roll-on is not a known mechanism for failing a urine drug test — systemic absorption from topicals is minimal in the literature. Individual testing programs vary, however. If your employer's drug-testing program tests hair (rarer), or if your topical is full-spectrum, bring the batch COA to your compliance team if you need documentation.

Both are gut-mediated, so onset is similar (60–90 min from swallow). Gummies have a slower release because the pectin base meters out the cannabinoid as it digests. Softgels with an MCT fill tend to absorb a touch faster. The practical difference for most customers is taste, format preference, and the sucrose content of the gummy.

Yes — pectin-set, not gelatin. The fruit base is real concentrate (not flavoring oil). No corn syrup, no artificial coloring. The pectin lets us avoid the gelatin question without losing the mouthfeel of a proper gummy.

Yes — they're designed to work as a stack. The cream is localized; the softgel is systemic. The Recovery Stack Bundle on this page pairs them with the Roll-On for a complete routine at a $16 savings over individual SKUs.

Topicals carry minimal systemic absorption, so drug-interaction risk is lower than with sublingual or gut-mediated formats — but it's not zero, particularly with frequent use over large body areas. Edibles carry the same drug-interaction profile as capsules. Talk to your healthcare provider before starting if you take Rx medication. We are not a substitute for medical advice and these statements are not evaluated by the FDA.